Literature DB >> 15772388

Resting energy expenditure in the parenterally fed pediatric population with Crohn's disease.

Kathryn Cormier1, Diana Mager, Louise Bannister, Marie Fortin, Helen Richards, Cheryl Jackson, Paul Pencharz.   

Abstract

BACKGROUND: Malnutrition is a common sequela of Crohn's disease (CD) and may result in reduced skeletal muscle function and growth retardation. Energy requirements of parenterally fed hospitalized pediatric patients with active CD were measured using indirect calorimetry, to assess whether Food Agriculture Organization (FAO)/World Health Organization (WHO)/United Nations University (UNU) equations provide appropriate estimations of energy requirements in this patient population.
METHODS: Twenty hospitalized patients with active CD fed exclusively via parenteral nutrition (PN) were investigated. A chart review and patient interviews were conducted to assess disease duration, location, laboratory parameters, and symptomology associated with CD. Disease severity was quantified using the Pediatric Crohn's Disease Activity Index. Each subject underwent indirect calorimetry, bioelectrical impedance analysis, and anthropometric assessment once the ordered PN met estimated macronutrient requirements of each patient (predicted resting energy expenditure x1.3). Predicted resting energy expenditure (REE) was determined using the FAO/WHO/UNU equations.
RESULTS: REE showed a strong correlation with predicted REE (r(2) = .73, p < .01).
CONCLUSIONS: Measured REE did not significantly differ from predicted resting energy requirements. This indicates that REE for the parenterally fed pediatric patients with CD can be accurately predicted using the FAO/WHO/UNU equations.

Entities:  

Mesh:

Year:  2005        PMID: 15772388     DOI: 10.1177/0148607105029002102

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  1 in total

1.  Reproduction and Growth in a Murine Model of Early Life-Onset Inflammatory Bowel Disease.

Authors:  Eniko Nagy; Ramona M Rodriguiz; William C Wetsel; Nancie J MacIver; Laura P Hale
Journal:  PLoS One       Date:  2016-04-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.